share_log

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

6-K:外國發行人報告
美股SEC公告 ·  04/29 06:22
Moomoo AI 已提取核心訊息
Alterity Therapeutics Limited, a development stage enterprise, has announced the application for quotation of additional securities on the ASX. The announcement, dated April 29, 2024, specifies that 7,097,419 ordinary fully paid shares will be quoted following the exercise of options or conversion of other convertible securities. These shares were issued on April 22, 2024, at an issue price of AUD 0.007 each. The new securities will rank equally with the existing issued securities in that class. Following this quotation, Alterity Therapeutics' issued capital will include over 5 billion ordinary shares and a variety of options with different expiration dates and exercise prices.
Alterity Therapeutics Limited, a development stage enterprise, has announced the application for quotation of additional securities on the ASX. The announcement, dated April 29, 2024, specifies that 7,097,419 ordinary fully paid shares will be quoted following the exercise of options or conversion of other convertible securities. These shares were issued on April 22, 2024, at an issue price of AUD 0.007 each. The new securities will rank equally with the existing issued securities in that class. Following this quotation, Alterity Therapeutics' issued capital will include over 5 billion ordinary shares and a variety of options with different expiration dates and exercise prices.
處於發展階段的企業Alterity Therapeutics Limited已宣佈在澳大利亞證券交易所申請額外證券的報價。該公告於2024年4月29日發佈,其中規定,在行使期權或轉換其他可轉換證券後,將對7,097,419股全額支付的普通股進行報價。這些股票於2024年4月22日發行,每股發行價爲0.007澳元。新證券的排名將與該類別中現有已發行證券的排名相同。在本次報價之後,Alterity Therapeutics的已發行資本將包括超過50億股普通股和各種具有不同到期日和行使價的期權。
處於發展階段的企業Alterity Therapeutics Limited已宣佈在澳大利亞證券交易所申請額外證券的報價。該公告於2024年4月29日發佈,其中規定,在行使期權或轉換其他可轉換證券後,將對7,097,419股全額支付的普通股進行報價。這些股票於2024年4月22日發行,每股發行價爲0.007澳元。新證券的排名將與該類別中現有已發行證券的排名相同。在本次報價之後,Alterity Therapeutics的已發行資本將包括超過50億股普通股和各種具有不同到期日和行使價的期權。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息